Structure	Catalog	Product Name	CAS	E3 Ligase	Target	Inquiry
	BPL-201433	N-(4-Cyano-3-(trifluoromethyl)phenyl)-3-(4-(2-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)ethoxy)ethoxy)ethoxy)ethoxy)phenoxy)-2-hydroxy-2-methylpropanamide	2540585-38-2	CRBN	AR	Inquiry
Molecular Weight: 812.75 Molecular Formula: C39H39F3N4O12 Boiling Point: 1001.2±65.0°C at 760 Torr Density: 1.46±0.1 g/cm3 Description: It is an androgen receptor PROTAC.
	BPL-201434	N-(4-Cyano-3-(trifluoromethyl)phenyl)-3-(4-(2-(2-(2-(2-((2-((S)-2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)ethoxy)ethoxy)ethoxy)ethoxy)phenoxy)-2-hydroxy-2-methylpropanamide	2771318-71-7	CRBN	AR	Inquiry
Molecular Weight: 798.77 Molecular Formula: C39H41F3N4O11 Boiling Point: 1015.9±65.0°C at 760 Torr Density: 1.42±0.1 g/cm3 Description: It is an androgen receptor PROTAC.
	BPL-201435	4-(4-(4-(2-(2-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)ethoxy)ethoxy)ethoxy)ethoxy)phenyl)-3,4-dimethyl-2,5-dioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile	2540585-21-3	CRBN	AR	Inquiry
Molecular Weight: 821.76 Molecular Formula: C40H38F3N5O11 Density: 1.48±0.1 g/cm3 Description: It is an androgen receptor PROTAC.
	BPL-201436	4-(4-(4-(2-(2-(2-(2-((2-((S)-2,6-Dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)ethoxy)ethoxy)ethoxy)ethoxy)phenyl)-3,4-dimethyl-2,5-dioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile	2550755-69-4	CRBN	AR	Inquiry
Molecular Weight: 807.78 Molecular Formula: C40H40F3N5O10 Density: 1.45±0.1 g/cm3 Description: It is an androgen receptor PROTAC.
	BPL-201437	4-(3-(4-(2-(2-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)ethoxy)ethoxy)ethoxy)ethoxy)phenyl)-4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile	2550755-72-9	CRBN	AR	Inquiry
Molecular Weight: 837.83 Molecular Formula: C40H38F3N5O10S Density: 1.49±0.1 g/cm3 Description: It is an androgen receptor PROTAC.
	BPL-201438	(S)-4-(3-(4-(2-(2-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)ethoxy)ethoxy)ethoxy)ethoxy)phenyl)-4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile	2540590-73-4	CRBN	AR	Inquiry
Molecular Weight: 823.85 Molecular Formula: C40H40F3N5O9S Density: 1.46±0.1 g/cm3 Description: It is an androgen receptor PROTAC.
	BPL-201439	(2S,4R)-1-((S)-2-(2-(3-(4-(4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)phenoxy)butoxy)propoxy)acetamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide	1973402-53-7	VHL	AR	Inquiry
Molecular Weight: 1006.18 Molecular Formula: C50H58F3N7O8S2 Density: 1.38±0.1 g/cm3 Description: It is an androgen receptor PROTAC.
	BPL-201440	(2S,4R)-1-((S)-2-(2-((5-(3-(4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)phenoxy)propoxy)-2,2,3,3,4,4-hexafluoropentyl)oxy)acetamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide	2550756-04-0	VHL	AR	Inquiry
Molecular Weight: 1128.15 Molecular Formula: C51H54F9N7O8S2 Density: 1.45±0.1 g/cm3 Description: It is an androgen receptor PROTAC.
	BPL-201441	(2S,4R)-1-((S)-14-(tert-Butyl)-1-(4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)phenoxy)-12-oxo-3,6,9-trioxa-13-azapentadecan-15-oyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide	2550756-06-2	VHL	AR	Inquiry
Molecular Weight: 1022.18 Molecular Formula: C50H58F3N7O9S2 Density: 1.39±0.1 g/cm3 Description: It is an androgen receptor PROTAC.
	BPL-201442	(2S,4R)-1-((S)-2-(2-(3-((4'-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-[1,1'-biphenyl]-4-yl)oxy)propoxy)acetamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide	1973403-02-9	VHL	AR	Inquiry
Molecular Weight: 1010.17 Molecular Formula: C52H54F3N7O7S2 Density: 1.40±0.1 g/cm3 Description: It is an androgen receptor PROTAC.
	BPL-201443	(2S,4R)-1-((S)-2-(2-(3-((4'-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-[1,1'-biphenyl]-4-yl)oxy)-2,2-difluoropropoxy)acetamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide	2550756-15-3	VHL	AR	Inquiry
Molecular Weight: 1046.15 Molecular Formula: C52H52F5N7O7S2 Density: 1.44±0.1 g/cm3 Description: It is an androgen receptor PROTAC.
	BPL-201444	(2S,4R)-1-((S)-2-(2-(3-(4-(4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)phenoxy)-2,2,3,3-tetrafluorobutoxy)propoxy)acetamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide	2550756-20-0	VHL	AR	Inquiry
Molecular Weight: 1078.14 Molecular Formula: C50H54F7N7O8S2 Density: 1.43±0.1 g/cm3 Description: It is an androgen receptor PROTAC.
	BPL-201445	(2S,4R)-1-((S)-2-(3-(2-(2-(4-(((1r,3r)-3-(4-Cyano-3-(trifluoromethyl)phenoxy)-2,2,4,4-tetramethylcyclobutyl)carbamoyl)phenoxy)ethoxy)ethoxy)propanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide		VHL	AR	Inquiry
Molecular Weight: 1005.17 Molecular Formula: C52H63F3N6O9S Boiling Point: 1109.1±65.0°C at 760 Torr Density: 1.32±0.1 g/cm3 Description: It is an androgen receptor PROTAC.
	BPL-201446	(2S,4R)-1-((S)-2-(2-((5-(4-(((1r,3r)-3-(4-Cyano-3-(trifluoromethyl)phenoxy)-2,2,4,4-tetramethylcyclobutyl)carbamoyl)phenoxy)pentyl)oxy)acetamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide	1973403-83-6	VHL	AR	Inquiry
Molecular Weight: 989.17 Molecular Formula: C52H63F3N6O8S Boiling Point: 1096.6±65.0°C at 760 Torr Density: 1.31±0.1 g/cm3 Description: It is an androgen receptor PROTAC.
	BPL-201447	(2S,4R)-1-((S)-3,3-Dimethyl-2-(2-(2-(2-((2-(4-(methylamino)phenyl)benzo[d]thiazol-6-yl)oxy)ethoxy)ethoxy)acetamido)butanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide	2412273-73-3	VHL	Alpha-syn	Inquiry
Molecular Weight: 829.06 Molecular Formula: C43H52N6O7S2 Density: 1.286±0.06 g/cm3 Description: It is a PROTAC that targets α-synuclein protein for the treatment of neurogenerative disorders (Alzheimer's and Parkinson's diseases).
	BPL-201448	(2S,4R)-1-((S)-2-(tert-Butyl)-20-((2-(4-(methylamino)phenyl)benzo[d]thiazol-6-yl)oxy)-4-oxo-6,9,12,15,18-pentaoxa-3-azaicosanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide	2412273-76-6	VHL	Alpha-syn	Inquiry
Molecular Weight: 961.22 Molecular Formula: C49H64N6O10S2 Density: 1.260±0.06 g/cm3 Description: It is a PROTAC that targets α-synuclein protein for the treatment of neurogenerative disorders (Alzheimer's and Parkinson's diseases).
	BPL-201449	(2S,4R)-1-((S)-2-(tert-Butyl)-23-((2-(4-(methylamino)phenyl)benzo[d]thiazol-6-yl)oxy)-4-oxo-6,9,12,15,18,21-hexaoxa-3-azatricosanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide	2412273-77-7	VHL	Alpha-syn	Inquiry
Molecular Weight: 1005.27 Molecular Formula: C51H68N6O11S2 Density: 1.253±0.06 g/cm3 Description: It is a PROTAC that targets α-synuclein protein for the treatment of neurogenerative disorders (Alzheimer's and Parkinson's diseases).
	BPL-201450	(2S,4R)-1-((S)-3,3-Dimethyl-2-(2-(2-(2-(4-(((E)-3-((E)-3-(4-nitrophenyl)allylidene)-2-oxoindolin-1-yl)methyl)phenoxy)ethoxy)ethoxy)acetamido)butanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide	2412273-79-9	VHL	Alpha-syn	Inquiry
Molecular Weight: 971.15 Molecular Formula: C53H58N6O10S Boiling Point: 1122.5±65.0°C at 760 Torr Density: 1.319±0.06 g/cm3 Description: It is a PROTAC that targets α-synuclein protein for the treatment of neurogenerative disorders (Alzheimer's and Parkinson's diseases).
	BPL-201451	2-(2,6-Dioxo-3-piperidinyl)-5-[4-[3-[[trans-3-[(7-nitro-10H-phenothiazin-3-yl)oxy]cyclobutyl]oxy]propyl]-1-piperazinyl]-1H-isoindole-1,3(2H)-dione	2412274-02-1	CRBN	Alpha-syn	Inquiry
Molecular Weight: 712.79 Molecular Formula: C36H36N6O8S Boiling Point: 954.6±65.0°C at 760 Torr Density: 1.53±0.1 g/cm3 Description: It is a PROTAC that targets α-synuclein protein for the treatment of neurogenerative disorders (Alzheimer's and Parkinson's diseases).
	BPL-201452	(2S,4R)-1-((S)-3,3-Dimethyl-2-(2-(4-(2-(4-((1r,3r)-3-((7-nitro-10H-phenothiazin-3-yl)oxy)cyclobutoxy)piperidin-1-yl)ethyl)piperazin-1-yl)acetamido)butanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide	2412274-07-6	VHL	Alpha-syn	Inquiry
Molecular Weight: 1010.28 Molecular Formula: C52H67N9O8S2 Density: 1.38±0.1 g/cm3 Description: It is a PROTAC that targets α-synuclein protein for the treatment of neurogenerative disorders (Alzheimer's and Parkinson's diseases).

PROTAC Library